Juvion Life Sciences Sàrl

Juvion develops next-generation therapeutics to preserve neuron-muscle communication, preventing mobility decline and sarcopenia in aging individuals. Our AI-driven discovery platform accelerates compound screening, identifying effective solutions for age-related mobility loss. Juvion also integrates non-invasive neuromuscular monitoring technology, enabling real-time tracking of brain-to-muscle communication. With a B2B model, we partner with pharma, nutraceutical, and MedTech companies, offering scientifically validated therapeutics and licensing opportunities. Backed by strategic partnerships and non-dilutive funding, Juvion is advancing solutions that promote healthier aging, independence, and quality of life.